ArticleBMC rheumatology2022

Anti-drug antibodies and rheumatoid factor level in patients with rheumatoid arthritis using the infliximab biosimilar CT-P13.

Hideo Sakane et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.